The evaluation of recombinant, chimeric, tetravalent antihuman CD22 antibodies.
D000818:Animals; D000906:Antibodies / Q000737:chemistry*; D000911:Antibodies, Monoclonal / Q000737:chemistry; D015703:Antigens, CD / Q000737:chemistry*; D000944:Antigens, Differentiation, B-Lymphocyte / Q000737:chemistry*; D000970:Antineoplastic Agents / Q000494:pharmacology; D019540:Area Under Curve; D015815:Cell Adhesion Molecules / Q000737:chemistry*; D002455:Cell Division; D015922:Complement C1q / Q000737:chemistry; D019281:Dimerization; D004305:Dose-Response Relationship, Drug; D004591:Electrophoresis, Polyacrylamide Gel; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007694:Killer Cells, Natural / Q000378:metabolism; D037102:Lectins / Q000737:chemistry*; D008223:Lymphoma / Q000378:metabolism; D051379:Mice; D009369:Neoplasms / Q000628:therapy*; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000737:chemistry*; D051918:Sialic Acid Binding Ig-like Lectin 2; D013696:Temperature; D013997:Time Factors; D020298:U937 Cells
D000906:Antibodies; D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000944:Antigens, Differentiation, B-Lymphocyte; D000970:Antineoplastic Agents; C497867:CD22 protein, human; C497868:Cd22 protein, mouse; D015815:Cell Adhesion Molecules; D037102:Lectins; D011994:Recombinant Proteins; D051918:Sialic Acid Binding Ig-like Lectin 2; D015922:Complement C1q